RA CV Risk Modification — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Use QRISK3 and address each modifiable cardiovascular risk
The best answer is “Use QRISK3 and address each modifiable cardiovascular risk”. QRISK3 already includes rheumatoid arthritis as a predictor, so adding an automatic rheumatoid-arthritis multiplier would double-count that factor. Smoking, hypertension and lipid treatment should be addressed through current UK cardiovascular-prevention guidance. A fixed addition is not validated, inflammatory disease does not make risk assessment useless, and prevention should not wait for prolonged remission.
Reference: NICE NG238 cardiovascular risk assessment and lipid modification: https://www.nice.org.uk/guidance/ng238/chapter/Recommendations